The Lin28/let-7 Axis Regulates Glucose Metabolism

SummaryThe let-7 tumor suppressor microRNAs are known for their regulation of oncogenes, while the RNA-binding proteins Lin28a/b promote malignancy by inhibiting let-7 biogenesis. We have uncovered unexpected roles for the Lin28/let-7 pathway in regulating metabolism. When overexpressed in mice, both Lin28a and LIN28B promote an insulin-sensitized state that resists high-fat-diet induced diabetes. Conversely, muscle-specific loss of Lin28a or overexpression of let-7 results in insulin resistance and impaired glucose tolerance. These phenomena occur, in part, through the let-7-mediated repression of multiple components of the insulin-PI3K-mTOR pathway, including IGF1R, INSR, and IRS2. In addition, the mTOR inhibitor, rapamycin, abrogates Lin28a-mediated insulin sensitivity and enhanced glucose uptake. Moreover, let-7 targets are enriched for genes containing SNPs associated with type 2 diabetes and control of fasting glucose in human genome-wide association studies. These data establish the Lin28/let-7 pathway as a central regulator of mammalian glucose metabolism.

Graphical AbstractFigure optionsDownload high-quality image (188 K)Download as PowerPoint slideHighlights
► Lin28a/b promote glucose tolerance and insulin-sensitivity in mice
► Overexpression of let-7 microRNA impairs glucose tolerance in mice
► Lin28a/b promote and the let-7's repress components of insulin-PI3K-mTOR signaling
► Let-7 targets are enriched for type II diabetes-associated SNPs in human GWAS